Cargando…
Chemotherapeutic Sensitization of Leptomycin B Resistant Lung Cancer Cells by Pretreatment with Doxorubicin
The development of novel targeted therapies has become an important research focus for lung cancer treatment. Our previous study has shown leptomycin B (LMB) significantly inhibited proliferation of lung cancer cells; however, p53 wild type lung cancer cells were resistant to LMB. Therefore, the obj...
Autores principales: | Lu, Chuanwen, Shao, Changxia, Cobos, Everardo, Singh, Kamaleshwar P., Gao, Weimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296751/ https://www.ncbi.nlm.nih.gov/pubmed/22412944 http://dx.doi.org/10.1371/journal.pone.0032895 |
Ejemplares similares
-
Epigallocatechin-3-Gallate Enhances the Therapeutic Effects of Leptomycin B on Human Lung Cancer A549 Cells
por: Cromie, Meghan M., et al.
Publicado: (2015) -
Nuclear export inhibitor leptomycin B induces the appearance of novel forms of human Mdm2 protein
por: Menéndez, S, et al.
Publicado: (2003) -
Immunostimulatory effects on B cells by the chemotherapeutic drug Doxorubicin
por: Kinn, Johan M, et al.
Publicado: (2011) -
Long-term exposure to estrogen enhances chemotherapeutic efficacy potentially through epigenetic mechanism in human breast cancer cells
por: Chang, Yu-Wei, et al.
Publicado: (2017) -
Curcumin and Vitamin E Protect against Adverse Effects of Benzo[a]pyrene in Lung Epithelial Cells
por: Zhu, Wenbin, et al.
Publicado: (2014)